In the present study the cell surface expression of CD45 isoforms on normal
and neoplastic human B cells was correlated with splice products of the CD
45 mRNA, using RT-PCR technology. In non-Hodgkin's lymphoma cells in the le
ukemic phase (NHL) the majority of the cells expressed a high level of CD45
RA, while in CLL most of the cells expressed a low level. In the Raji and D
audi Burkitt B-cell lymphoma lines the main CD45 mRNA product was the large
st, unspliced, full-length isoform (456) and the 56 splice product. Similar
results were obtained with B-cell lymphoma cells isolated from the periphe
ral blood of patients with NHL in the leukemic phase. In EBV-transformed B-
cell lines, the 456 and the 56 isoform of CD45 mRNA were predominant, but i
n addition a low level of the 5- and 0-exon splice products was detected. A
strikingly different pattern was obtained with B-CLL cells. In CLL the lev
el of the 456 and the 56 isoforms was low, while that of the 5- and 0-exon
splice products was increased. Thus, in contrast to the heterogeneity in th
e expression of CD45RO in B-CLL, the majority of the cells contained the CD
45 mRNA splice product coding for CD45RO. Analysis of splice products of th
e CD45 mRNA may serve as an additional tool to differentiate CLL from the l
eukemic phase of NHL.